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Background: Posttraumatic stress disorder (PTSD) is one of the psychopathological
consequences of sexual and/or physical abuse. The economic burden is assumed to be
high, whereas health-related quality of life and education is negatively affected. This study
aims to determine health care costs, health-related quality of life, and educational
interruption in adolescents and young adults with PTSD after sexual and/or physical
abuse in Germany.
Methods: This analysis used data of 87 participants aged 14–21 years of a randomized
controlled trial. Health care utilization, health-related quality of life (EQ-5D-5L), sick leave
days, productivity, and delay or failure to achieve educational aims were assessed. Health
care costs from a payer perspective were calculated using unit costs for the year 2014.
Results: Mean health care costs for a six-month period were 5,243€ (SE 868€). In
particular, costs of inpatient stays in psychiatric hospitals, general hospitals and
rehabilitation as well as child welfare institutions were high. In addition, health-related
quality of life was lower due to anxiety/depression, resulting in a mean EQ-5D index and
EQ-VAS score of 0.70 and 61.0, respectively. Furthermore, participants reported on
average 27 sick leave days, a productivity loss of 61%, and a delay in education
attainment as well as having been unable to achieve educational aims.
Conclusion: PTSD in adolescents and young adults is associated with a high economic
burden. Health-related quality of life was substantially reduced. Furthermore, delay and
productivity losses in education were observed.
Clinical Trial Registration: German Clinical Trials Register identifier: DRKS00004787;
date of registration: 18th March 2013; https://www.drks.de.
Keywords: cost-of-illness, posttraumatic stress disorder, quality of life, economic burden, adolescentsg July 2020 | Volume 11 | Article 6971
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Posttraumatic stress disorder (PTSD) is characterised by distress
symptoms lasting more than one month following a traumatic
event, such as sexual and/or physical abuse, accidents or war
experiences. According to DSM-IV, PTSD is characterised by
intrusive reliving of the traumatic events, avoidance of reminders
of the trauma, and hyperarousal symptoms. Furthermore, patients
have to suffer from clinical distress, or experience difficulties in
social or occupational functioning to be diagnosed with PTSD (1).
The high lifetime prevalence of PTSD has been estimated by
numerous studies (2, 3). As it has been estimated that 30% to
40% of children after sexual or physical abuse develop PTSD (4),
PTSD in adolescents and young adults is rather frequent.
Patients often suffer from long-term consequences such as
mental and somatic comorbidities, unemployment and reduced
productivity as well as reduced quality of life (5–8). Moreover,
the consequence of PTSD, with respect to health care costs
(direct costs), impairments in working life (indirect costs) and
constraints on quality of life, can be significant (9).
International treatment guidelines as the one by the National
Institute for Health and Care Excellence (NICE) recommend
trauma-focused cognitive behavioural therapy or eye movement
desensitization and reprocessing therapy (10). Based on the results
in adults, Matulis et al. adapted Cognitive Processing Therapy
(CPT) (11) to the needs of adolescents and young adults
following abuse. Developmentally Adapted Cognitive Processing
(D-CPT)was introduced, which integrated fourmajor adjustments
of CPT tailored specifically to adolescent survivors of childhood
abuse suffering from PTSD (11). To facilitate the motivation of
adolescents to participate in treatment, a commitment phase was
integrated and the frequency of treatment sessions was increased.
Furthermore, behaviour and emotion management techniques
suitable for adolescents were included. Specifically, the therapy
focusesondifficulties in emotion regulation,whichoften occur after
sexual or physical childhood abuse. Finally, developmental tasks
tailored to the situation of each patient were established. For
example, a goal may seek to minimise the risk of patients of
future revictimization and/or the risk of patients selecting an
abusive partner.
Even though the consequences of PTSD are significant, only a
limited number of health economic studies addressing PTSD
after sexual abuse exist (7, 12–16). Most of these studies analyzed
data of adult patients with PTSD (12–14). The economic burden
was reported to be high. Annual costs ranged between 3,060 US$
and 18,100€ per adult patient. Costs due to psychiatric treatment
were reported to be particularly high in a German study of adults
with PTSD (12). However, in younger age groups, PTSD may
have a specific impact on the utilisation of health care and
health-related quality of life, as well as on the educational
development of patients.
To our knowledge, only one empirical health economics study
that focusses on cost of illness of adolescents and young adults with
PTSD after sexual and/or physical childhood abuse in the UK has
been published (16). This study was an 11-week randomised
controlled trial, thus long-term effects were estimated using a
Markov model. Even though indirect costs might not be relevantFrontiers in Psychiatry | www.frontiersin.org 2in patients at a young age (as they do not participate in the labour
market yet), educational interruption may have an influence on
future indirect costs. Several studies evaluated by a review (17) have
addressed the effects of traumatic experience on school
performance. However, this review focused on adolescents or
young adults with maltreatment, rather than on adolescents after
sexual and/or physical childhood abuse. Thus, these effects on
school performance are still unknown. Beyond costs, the burden
of PTSD may be described by the impact of PTSD on patients’
health-related quality of life. In health economic research, the EQ-
5D is the most frequently used generic quality of life questionnaire.
To our knowledge, health-related quality of life of adolescents and
young adults with PTSDmeasured by the EQ-5D has not yet been
published in the literature.
Therefore, this study estimated the economic consequences of
PTSD with respect to health care utilisation, costs and health-
related quality of life for adolescents and young adults with
PTSD in Germany. In addition, it determined the impact of
PTSD on educational interruption, which could be considered as
an indicator of future indirect costs.METHODS
Study Design and Participants
This study used baseline data on health care utilisation and health-
related quality of life of participants enrolled in a multicentre
randomized controlled trial (RCT) for adolescents and young
adults with PTSD (18, 19). Study participants were recruited
through therapists, psychiatric clinics and youth welfare
institutions as well as flyers and press releases. Screening,
assessment and therapy took place at German outpatient
university clinics in Berlin, Frankfurt/Main, and Eichstätt/
Ingolstadt. Participants were enrolled between July 23, 2013 and
June17, 2015. Informedconsentwasobtained fromtheparticipants
and if participants were 18 years old or less, informed consent was
obtained from their parents or legal guardians.
Participants with a primary diagnosis of PTSD related to
childhood sexual and/or physical abuse were eligible to participate,
provided they were also between the ages of 14 and 21, had no or a
stablepsychopharmacologicalmedication(for≥3weeks)and lived in
stable conditions. Furthermore, sufficient knowledge of German
language was required. Participants with current severe or life-
threatening suicidality or self-harming behaviour within the last 6
month, IQ ≤ 75, current substance dependence (abstinence < 6
months), or a substance-induced disorder, any documented
pervasive developmental disorder, lifetime psychotic or bipolar
disorder (unclear cases were included) according to the DSM-IV-
TR (1), as well as simultaneous psychotherapeutic treatment, were
excluded. Participantswere randomized to treatmentwithD-CPTor
wait-list condition with treatment advice (WL/TA)). Participants
withat least twoavoidance symptoms in theclinical interviewdefined
in the DSM-IV-TR (1) were diagnosed with PTSD. Analyses were
based on data from the included participants with information on
health care utilisation at baseline (n=87). A detailed description of
study design and treatment options as well as results in clinical
outcomes can be found elsewhere (18, 19).July 2020 | Volume 11 | Article 697
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Parameters
Socio-demographics included individual characteristics (e.g., age,
gender, migration status) as well as family background (number
of siblings, parental marital status), living situation, education
and educational level of the parents. Clinical parameters
included information on previous treatment and the severity of
PTSD as measured by the Clinician Administered PTSD Scale for
Children and Adolescents (CAPS-CA) (20, 21). The CAPS-CA
rates frequency and intensity of PTSD symptoms from 0 (never/
no problem) to 4 (most of the time/extreme problem), with a
total score ranging from 0 (best) to 136 (worst). In addition,
participants were asked to complete a wide range of
questionnaires to determine the presence and severity of
specific psychiatric comorbidities (e.g., Structured Clinical
Interview for DSM Disorders (SCID) (22–24), the Diagnostic
Interview of Mental Disorders in Childhood and Adolescence
(Kinder-DIPS) (25), the nicotine section of the Expert System for
Diagnosing Mental Disorders (DIA-X) (26).
Health Care Costs
Health care utilisation during the six months prior to baseline was
assessed using an adapted version of the Client Socio-demographic
and Service Receipt Inventory (CSSRI) questionnaire (27).
Utilisation of health care was monetarily valued using German
unit costs for each health care category for the year 2014
(Supplementary Material, Table S1) (28). We calculated health
care costs from a payer perspective. Costs included stays in general
hospitals, psychiatric hospitals, or rehabilitation clinics, outpatient
physician and non-physician (e.g., occupational therapy,
physiotherapy) services as well as medication. Medication costs
were derived from the German official pharmaceutical index (Rote
Liste) (29). Furthermore, the services of youth welfare, social
counselling, and child welfare institutions (living in a foster
family or in an apartment with other adolescents, assisted by
social workers) were included.
Health-Related Quality of Life
Health-related quality of life was assessed by the EQ-5D-5L (30,
31) which records problems across the dimensions of “mobility”,
“self-care”, “usual activities”, “pain/discomfort”, and “anxiety/
depression”. Participants rate their experience on an ordinal
scale with “no problems”, “slight problems”, “moderate
problems”, “severe problems” to “extreme problems”. As
persons filling in the EQ-5D-5L are asked to choose one out of
five levels for each of the five dimensions, the EQ-5D-5L
descriptive system describes 3125 (55) different health states,
which could be transferred to the EQ-5D index. The EQ-5D
index is a score between -0.661 (extreme problems) and 1 (best
possible health) (32). In addition, quality of life was measured by
the visual analogue scale of the EQ-5D (EQ-VAS) on a scale
between 0 (worst) and 100 (best) (30).
Education
Educational interruptions were assessed by questions concerning
school education and professional training, including the
number of days absent from school/professional training dueFrontiers in Psychiatry | www.frontiersin.org 3to PTSD over the previous six months. Even if patients had
participated at school/professional training, productivity loss
might have occurred. Therefore, productivity loss at school/
professional training due to PTSD was considered using a
visual analogue scale ranging from 0 (“no productivity loss”) to
10 (“complete productivity loss”). In addition, educational delays
due to PTSD were assessed by asking for repeated years at school.
Furthermore, participants reported failed school graduation or
professional training graduation due to PTSD. Finally, problems
in finding a professional training position or job were evaluated
by a visual analogue scale between 0 (“no problems”) and 10
(“severe problems”). As most participants did not complete
school yet, educational interruptions and productivity loss at
school were not monetarily valued.
Statistical Analysis
The maximum missing rate per variable in the evaluated data set
was 23% for sick leave days at school. Of all participants, 10% did
not report their achieved educational level or their health care
utilisation for inpatient stays in general hospitals and rehabilitation.
In 5% to 10% of all cases information on child welfare institutions,
outpatient physician visits, counselling, and inpatient stays in
psychiatric hospitals was missing. The proportions of missing
values for all other variables were 5% or less. Even though no
common threshold for an inconsequential proportion of missing
data is reported in the literature, the use of imputation methods for
missing rates above 5% is recommended (33). As the missing rate
for some essential variables (sick leave days, inpatient stays in
general hospitals and rehabilitation) in the current data were
above 5%, missing values were imputed to avoid a loss in
statistical power. We used multiple imputation by chained
equations (MICE) with predictive mean matching to create 50
imputations (33, 34).
We analyzed costs, health-related quality of life and variables
on education/professional training using descriptive statistics,
and determined the influence of age, gender, CAPS-CA total
score, and psychiatric comorbidities on costs and health-related
quality of life to identify subgroups of patients with increased
and decreased costs or health-related quality of life. For total cost
data generalized linear models (GLMs) with a Gamma
distribution and a log-link function were used, whereas health-
related quality of life was analyzed using linear regression. For all
analyses, a significance level of 5% was applied.
Subgroup analyses determined costs by study centres and
treatment options. Differences between subgroups were tested
using regression analyses adjusted for age, gender, CAPS-CA
total score, and psychiatric comorbidities.
All computations were conducted with R (3.5.1). In particular,
the R-package “mice” was used for multiple imputation (35).RESULTS
Sample Characteristics
Participants had a mean age of 18.1 (SD 2.3) years, and 15% were
male (Table 1). The mean CAPS-CA total score was 64.7 (SD
21.7). On average participants had 1.9 (SD 1.5) psychiatricJuly 2020 | Volume 11 | Article 697
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undergone outpatient psychotherapy and 44% had at least one
psychiatric hospital stay.
Costs
Mean total costs were 5,243€ (SE 868) for the 6-month prior to
baseline (Table 2). Of these costs, 50% were due to inpatient
psychiatric hospitals (1,198€, SE 510), general hospitals (936€, SE
217), and rehabilitation hospitals (450€, SE 204). Half of the costs
were due to outpatient services, in particular child welfare
institutions (1,638€, SE 483), and outpatient physician treatment
(696€, SE 80). Neither gender, the CAPS-CA total score nor the
number of psychiatric comorbidities were related significantly to
costs (Table 3). Unadjusted subgroup analyses revealed differences
in costs due to study centre and treatment options (Supplementary
Material, Tables S2 and S3). However, after adjusting for
sociodemographic and clinical characteristics, no statistically
significant group differences were observed.
Health-Related Quality of Life
Health-related quality of life asmeasured by the EQ-5D-5Lwasmost
strongly affected by the dimension of anxiety/depressionwith 13%of
the participants reporting extreme, 22% severe, and 35% moderate
problems (Table 4). Furthermore, participants frequently reported
problems in the dimension of pain/discomfort, with 13% reporting
severe or extreme problems and 32% moderate problems. Less
problems were reported in the dimensions of mobility and usualFrontiers in Psychiatry | www.frontiersin.org 4activities. Furthermore, participants were rarely impaired with
respect to the dimension of self-care. The mean EQ-5D index and
EQ-VAS score were 0.70 (SE 0.03) and 61.0 (SE 2.4), respectively.
Analysis on determinants of health-related quality of life
revealed that the EQ-5D index was not statistically significantly
different between males and females. Furthermore with increasing
CAPS-CA total score the EQ-5D index was significantly reduced
(Table 5).Neither gender, theCAPS-CAtotal scorenor thenumber
of psychiatric comorbidities showed any significant relation to the
EQ-VAS.
Education
Participants reported on average 27 sick-leave days in school/
professional training in the prior six months. Furthermore, a
productivity loss of 61% was measured. Long-term effects on
education were appraised according to delays in achieving
educational aims. Overall, 24 participants had repeated a year
in school. Of those, 30% repeated the year at the end of secondary
school. Furthermore, 25 participants reported to have failed
school graduation or professional training graduation due to
PTSD. Even though only 42 adolescent participants hadTABLE 1 | Sample characteristics (n=87).
Demographics
age mean | SD 18.1 2.3
male gender n | % 13 14.9
secondary school degree or higher n | % 11 12.6
number of siblings mean | SD 2.3 2.0
Severity of disease
CAPS-CA total score mean | SD 64.7 21.7
Comorbidities




n | % 53 60.9
previous inpatient psychotherapies/psychiatric
therapies >=1
n | % 38 43.7CAPS-CA, Clinician Administered PTSD Scale for Children and Adolescents.TABLE 2 | Six-month costs in 2014 Euros (n=87).
mean median SE range % of total costs % of the sample
with utilization
general hospital 936 0 217 0-8,220 18 18
psychiatric hospital 1,198 0 510 0-29,095 23 8
rehabilitation 450 0 204 0-12,175 9 6
outpatient physician treatment 696 483 80 0-3,824 13 97
psychotherapy/psychiatric/neurological 401 159 66 0-3,582 8 53
outpatient non-physician treatment 20 0 11 0-765 0 7
medication 58 0 13 0-727 1 46
child welfare institutions 1,638 0 483 0-14,396 31 16
counselling 247 0 70 0-4,529 5 38
total costs 5,243 949 868 20-21,243 100 100July 2020 | VolumTABLE 3 | Determinants of costs (n=87).
Parameters coefficient SE p-
value
95% CI
age 0.94 0.08 0.39 0.80 1.09
gender (female=0, male=1) 1.46 0.48 0.43 0.56 3.78
CAPS-CA total score 1.00 0.01 0.79 0.98 1.02
number of psychiatric
comorbidities
1.06 0.13 0.63 0.82 1.37
intercept 16,240 1.49 0.00 842 313,180e 11 | ACAPS-CA, Clinician Administered PTSD Scale for Children and Adolescents.TABLE 4 | EQ-5D-5L (n=87).
n (%) of participants with problems
EQ-5D-5L dimensions “no” “slight” “moderate” “severe” “extreme”
mobility 62 (71) 17 (20) 7 (8) 1 (1) 0 (0)
self-care 82 (94) 3 (4) 0 (0) 2 (2) 0 (0)
usual activities 37 (43) 23 (26) 16 (18) 6 (7) 5 (6)
pain/discomfort 23 (26) 25 (29) 28 (32) 8 (9) 3 (4)
anxiety/depression 9 (10) 17 (20) 31 (35) 19 (22) 11 (13)EQ-5D-5L, Euro-QoL- 5 dimensions – 5 levels.rticle 697
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unable to pursue their preferred job. Furthermore, these
participants rated problems in finding a professional training
or job to be 1.5 on scale between 0 (“no problems”) and 10
(“severe problems”).DISCUSSION
Our analyses revealed a high burden of direct costs, reduced
health-related quality of life and educational interruption among
adolescents and young adults with PTSD.
Costs
Costs were mainly due to psychiatric hospitals, general hospitals
and rehabilitation. As most of the participants had at least one
psychiatric comorbidity, inpatient costs may be due to these. In
addition, high costs were due to the utilisation of child welfare
institutions. Of all participants, 15% were living neither at home
nor with relatives/friends. The trigger of the disease may be the
reason, as it is often located in the family environment. Almost
every participant used outpatient physician treatment. Yet,
compared to inpatient treatment costs, only moderate outpatient
treatment costs were observed. More than half of the outpatient
treatment costs were due to psychological treatment.
To our knowledge, one study has estimated cost of PTSD in
children and adolescents (16) and only two studies have estimated
costs of PTSD in children (7, 15). The first cost-utility analysis was
based on an 11-week trial, which revealed health care costs of 557
£ in the UK (16). In accordance with our results inpatient costs
and community services were high. Another study estimated
intervention costs for three treatment strategies for Australian
children with PTSD after sexual abuse (7). In this study, costs were
not measured empirically but were estimated based on expert
opinion. Intervention costs of cognitive behaviour therapy (CBT),
CBT combined with selective serotonin reuptake inhibitor, and
non-directive counselling were compared. Over a 12-month
period intervention costs of 2,074 AUD for non-directive
counselling, 2,051 AUD for CBT only, and 2,226 AUD for CBT
combined with selective serotonin reuptake inhibitor were
calculated. Yet, only intervention costs were included. The last
trial considered children with PTSD in the USA, however the
study did not specifically pertain to participants who had
experiences of sexual abuse (15). Mental health care costs
including costs for crisis centres, counselling and community
support, and medical supervision for participants treated withFrontiers in Psychiatry | www.frontiersin.org 5CBT were compared with services-as-usual. Total annual costs
were 3,055 USD for participants treated with CBT and 4,208 USD
for participants receiving services-as-usual. In particular,
outpatient costs were high compared with our results,
respectively. Higher costs compared with our results were
expected due to the treatment with CBT or services-as-usual,
whereas our study included participants pre-treatment. Yet, data
did not include all relevant costs categories (15). Costs of
medication, counselling or child welfare institutions were
not considered.
Unfortunately, no cost data for young patients with PTSD or
a representative sample of adolescents and young adults of the
general population in Germany have been published. One study
reported costs for the German health care system for adult with
PTSD (12). In line with our results, high 6-month costs for
psychiatric inpatient (7,596€) and outpatient (825€) treatment
were observed. Yet, our results for psychiatric inpatient costs in
adolescents and young adults were lower (1,198€ for 6 months).
Specifically, adolescents spent fewer days in psychiatric hospitals
compared with adults (3 vs. 45 days), which was expected as
adolescents were offered outpatient treatment, whereas adults
were treated in inpatient settings. In addition, costs for
outpatient psychotherapy were more than twice as high in
adults compared with our results (825€ vs. 401€) which in
addition to the treatment location may be explained by fewer
comorbidities due to the younger age.
Health-Related Quality of Life
Health-related quality of life in adolescents and young adults with
PTSD was markedly reduced. Participants indicated a mean EQ-
5D Index and EQ-VAS score of 0.70 and 61.0, respectively. Our
results showed considerable impairments for participants with
PTSD, when compared with a representative German population
sample aged between 8 and 18 years (35). Persons of the general
population reported an average EQ-VAS score of 83.5.
On the EQ-5D-5L dimension anxiety/depression, 13% and 22%
of the participants reported extreme and severe problems, whereas
only 2% in the general populations were impaired extremely or
severely. Furthermore, 90% of the participants with PTSD reported
to have any problems due to anxiety/depression, which was much
more frequent compared with only 22% of the general population.
In addition to problems due to anxiety/depression, our results
indicated problems of adolescents and young adults with PTSD in
the EQ-5D-5L dimension of pain/discomfort. Whilst only 2% and
26% of the general population reported to have extreme/severe and
slight/moderate problems respectively, 13% and 61% of theTABLE 5 | Determinants of health-related quality of life measured by the EQ-VAS and EQ-5D index (n=87).
parameters EQ-VAS EQ-5D index
coefficient SE p-value 95% CI coefficient SE p-value 95%CI
age -0.52 1.02 0.61 -2.54 1.50 0.00 0.01 1.00 -0.02 0.02
gender (female=0, male=1) 3.03 6.34 0.63 -9.58 15.64 -0.10 0.07 0.14 -0.23 0.04
CAPS-CA total score -0.23 0.12 0.05 -0.46 0.00 -0.01 0.00 0.00 -0.01 0.00
number of psychiatric comorbidities -3.00 1.64 0.07 -6.27 0.27 -0.00 0.07 0.99 -0.04 0.03
intercept 91 20 0.00 52 130 1.12 0.21 0.00 0.71 1.53July 2020 | Volume 11 | ArticleSE, standard error; CI, confidence intervals; EQ-VAS, visual analogue scale of the EQ-5D; CAPS-CA, Clinician Administered PTSD Scale for Children and Adolescents.697
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Furthermore, participants with PTSD reported more problems in
the dimensions of mobility and usual activities, although less
frequently than in the dimensions of anxiety/depression and pain/
discomfort. Problems with usual activities were rated to be extreme/
severe or slight/moderate by 13% and 44% of the participants,
whereas only 1% and 12% of the persons of the general population
reported such problems. Furthermore, 28% of the participants with
PTSD experienced slight/moderate problems in the dimension of
mobility compared to 4% in the general population. Both problems
due to mobility, as well as usual activities may be due to the desire
among those diagnosed with PTSD to avoid the re-experience of the
traumatic event and/or the hyperarousal caused by the traumatic
event. For both, persons with PTSD and the general population,
only few problems were reported on the dimensions self-care, where
more than 94% experienced no problems. In conclusion, health-
related quality of life was decreased among adolescents and young
adults with PTSD. In particular, anxiety/depression seems to have a
substantial influence.
To our knowledge only one other studies reported health-
related quality of life for children with PTSD aged between 9 and
11 years (17). Participants reported mild to moderate impairments
on the Life Satisfaction Scale, thus our findings confirm
previous results.
Education
During a six-month period, adolescents and young adults with
PTSD had on average 27 sick leave days in school/professional
training. Productivity was reduced by 61%.
In line with our results, a recently published systematic review
considering the impact of traumatic experiences on school
performances revealed a reduced school performance of
participants with PTSD (36). Furthermore, studies reported a
delay in educational attainment by repeating a year at school
(37–40). To compare our results with data of the German
population we used data from the federal statistical office (41).
The mean probability of repeating one specific year at school was
1.33%. Thus, for n=87 participants and an assumed 11-year
school education at the age of 18 years, we would expected 15
participants to have repeated one year. Indeed, 24 adolescents
and young adults with PTSD repeated one year.
Furthermore, adolescents and young adults with PTSD had
achieved a lower educational level compared with the German
population (41). Specifically, participants with PTSD less
frequently completed a technical college or an A-level exam.
As most participants had not completed school, our results may
not be directly comparable with data from the federal statistical
office. However, 42 participants had completed their school/
professional training, and half of them were unable to start or
complete their preferred job.
Strength and Limitations
Even though PTSD is highly prevalent and has significant
consequences, only a small number of studies have examined
its effects on costs, health-related quality of life and education inFrontiers in Psychiatry | www.frontiersin.org 6adolescents and young adults. Although the estimated number of
unreported cases of abuse-related PTSD is high, we were able to
provide empirical data of 87 adolescents and young adults with
PTSD to close this gap in the literature. The evaluation of
resource utilisation was adapted to the study population, and
the costs associated with the utilisation of the established CSSRI
youth welfare services, social counselling and child welfare
institutions were also assessed. Costs due to transport and
long-term nursing care were not assessed. Instead of indirect
costs due to absenteeism from work and productivity loss,
performance of adolescents and young adults with PTSD at
school/professional training were evaluated. Finally, we used
advanced statistical methods. Missing values were handled by
multiple imputation using MICE. MICE is widely used to impute
values missing (completely) at random, thus a loss of statistical
power was avoided. In addition, the skewness in cost data was
taken into account using GLMs assuming a Gamma distribution
and log-link function.
Even though the study was carried out carefully, it does
include some limitations. First, the sample size of the study
(n=87) was rather small. As the distribution of cost data was
skewed, the small sample size may have led to a bias in cost
calculations. Nevertheless, results showed a reduced quality of
life and high costs for adolescents and young adults with
PTSD. Second, multiple imputation using MICE requires
missing at random (MAR). Unfortunately, no statistical test
exists to distinguish between MAR and missing not at
random (MNAR), thus MNAR could not be ruled out.
However, sociodemographic statistics for persons, who did
not report health care utilization in major cost drivers
(psychiatric hospital, general hospital, outpatient non-
physician treatment, child welfare institutions), did not
differ compared with those of the complete sample. Finally,
almost half of the participants had not completed school yet.
Therefore, results on educational interruption cannot be
interpreted as long-term consequences of PTSD. In addition,
further problems may arise in later working life (e.g., when trying
to find a job). Therefore, future research should consider long-
term economic consequences of PTSD in adults after sexual and/
or physical abuse.
Finally, costs were collected independent of seasons for 6
months prior to baseline, so that the influence of seasons on
health care utilization could not be determined. However, a
seasonal influence on the results was not expected, because no
seasonal clinical events are known for PTSD.CONCLUSION
PTSD in adolescent and young adults has a high economic
burden. High costs due to inpatient stays in psychiatric
hospitals, general hospitals and rehabilitation as well as child
welfare institutions occurred. Health-related quality of life was
substantially reduced. Furthermore, considerable delays and
productivity losses in education were observed.July 2020 | Volume 11 | Article 697
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